Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-15

FDA Approved: ATOMOXETINE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic Atomoxetine product from Strides Pharma Science Limited, enabling market entry of the generic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

SUPPL AP for ATOMOXETINE (ATOMOXETINE)